Alph Bingham is a renowned expert in portfolio management, systems modeling, and design, organizational architecture, and innovation systems. With over 28 years of experience in the pharmaceutical industry and a Ph.D. in organic chemistry from Stanford University, he served in numerous executive positions at Eli Lilly and Company, including Vice President of R&D Strategy. Bingham is a passionate advocate of open innovation and has co-founded several companies that leverage networked organizational structures such as IncnoCentive, Coalesix, and Collaborative Drug Discovery. As a Visiting Scholar at the National Center for Supercomputing Application, he lectures extensively on innovation, risk management, and leadership strategy. Bingham received numerous awards for his work, including the Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. In summary, Alph Bingham's expertise in portfolio management, innovation strategy, and risk management, as well as his passion for open and networked organizational structures, has made him a thought leader in the field.